Rutgers Cancer Institute of New Jersey ( Site 3008)

New Brunswick, New Jersey 08901

1 studies enrolling now · 1 studies all time

What they study most

Malignant Neoplasm

Studies at this site

• A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) — Recruiting now